BMRN
USDBioMarin Pharmaceutical Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$52.560
Haut
$52.760
Bas
$51.800
Volume
2.96M
Fondamentaux de l'Entreprise
Capitalisation Boursière
10.1B
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
2.34M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Bernstein Maintains Outperform on BioMarin Pharmaceutical, Lowers Price Target to $88
Bernstein analyst William Pickering maintains BioMarin Pharmaceutical with a Outperform and lowers the price target from $95 to $88.
Truist Securities Maintains Buy on BioMarin Pharmaceutical, Lowers Price Target to $80
Truist Securities analyst Joon Lee maintains BioMarin Pharmaceutical with a Buy and lowers the price target from $90 to $80.
Wells Fargo Maintains Overweight on BioMarin Pharmaceutical, Lowers Price Target to $70
Wells Fargo analyst Mohit Bansal maintains BioMarin Pharmaceutical with a Overweight and lowers the price target from $90 to $70.
Barclays Maintains Overweight on BioMarin Pharmaceutical, Lowers Price Target to $80
Barclays analyst Gena Wang maintains BioMarin Pharmaceutical with a Overweight and lowers the price target from $86 to $80.
HC Wainwright & Co. Maintains Neutral on BioMarin Pharmaceutical, Lowers Price Target to $55
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains BioMarin Pharmaceutical with a Neutral and lowers the price target from $60 to $55.
Morgan Stanley Maintains Overweight on BioMarin Pharmaceutical, Lowers Price Target to $98
Morgan Stanley analyst Matthew Harrison maintains BioMarin Pharmaceutical with a Overweight and lowers the price target from $104 to $98.
BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced financial results for the third quarter ended September 30, 2025. "We are pleased with...
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.